Proskauer Rose advised Intapp, Latham & Watkins advised the underwriters, Sidley Austin advised Great Hill Equity Partners IV, L.P. and its affiliates, and Morrison & Foerster...
Intapp’s $228 Million Public Offering of Common Stock
ACELYRIN’s $621 Million Initial Public Offering
Cooley advised ACELYRIN, and Davis Polk advised the joint book-running managers. ACELYRIN, INC. announced its upsized initial public offering of 34,500,000 shares of common stock at...
Reneo Pharmaceuticals’ Common Stock Offering
Cooley advised Reneo, and Latham & Watkins advised the underwriters and placement agents. Reneo Pharmaceuticals, Inc. announced the pricing of its previously announced underwritten public offering of...
Gamida Cell’s $23 Million Follow-On Offering
Meitar and Cooley advised Gamida Cell on the offering, and Davis Polk advised the underwriter. Gamida Cell Ltd. announced the $23 million SEC-registered follow-on offering of...
TELA Bio’s $45.125 Million Common Stock Public Offering
Goodwin Procter advised TELA Bio, while Latham & Watkins advised the underwriters on the offering. TELA Bio, Inc. has announced the pricing of its previously announced underwritten...
Xponential Fitness’ $122.5 Million Secondary Offering of Class A Common Stock
Davis Polk is advising Xponential Fitness on the offering, and Latham & Watkins is advising the underwriters involved. Xponential Fitness, Inc. has announced the pricing of...
Expro’s $151.8 Million Secondary Offering
Davis Polk advised the joint book-running managers involved in the offering, while Gibson Dunn and Van Campen Liem advised Expro. The selling shareholders were assisted by...
Cactus’ $172.5 Million Offering of Common Stock
Davis Polk advised Cactus Inc. on the stock offering and Simpson Thacher advised the underwriters involved. Cactus Inc. announced its $172.5 million follow-on offering of 3,224,300 shares of...
Skyward Specialty’s $134 Million Upsized Initial Public Offering
DLA Piper advised Skyward Specialty, while Latham & Watkins LLP represented the underwriters in the offering. Skyward Specialty Insurance Group, Inc., a specialty insurance company, delivering...
Acrivon Therapeutics’ $99.4 Million Initial Public Offering
Goodwin Procter advised the underwriters on the deal. Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biopharmaceutical company developing precision oncology medicines...
Tenaya Therapeutics’ $75 Million Shares Offering
Wilson Sonsini Goodrich & Rosati advised Tenaya on the deal, while Davis Polk advised the joint book-running managers and representatives of the several underwriters. Clinical stage...
Nuvalent’s $264.5 Million Equity Offering
Simpson Thacher represented the underwriters in the offering. Nuvalent, Inc. (“Nuvalent”) executed its registered follow-on offering of 7,895,522 shares of Class A common stock. The offering...